# This is a Study to Determine the Antidepressant Effects of AZD6765

> **NCT00986479** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 22 (actual)

## Conditions studied

- Treatment Resistant Major Depressive Disorder

## Interventions

- **DRUG:** AZD6765
- **DRUG:** Placebo to AZD6765

## Key facts

- **NCT ID:** NCT00986479
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2014-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00986479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00986479, "This is a Study to Determine the Antidepressant Effects of AZD6765". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00986479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*